Design and rationale of a first-in-human (FIH) phase 1/1b study evaluating KIN-3

Discussion Board Forums Clinical Trials Design and rationale of a first-in-human (FIH) phase 1/1b study evaluating KIN-3

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #101724
    gavin
    Moderator

    Design and rationale of a first-in-human (FIH) phase 1/1b study evaluating KIN-3248, a next-generation, irreversible (irrev), pan-FGFR inhibitor (FGFRi), in adult patients with solid tumors harboring FGFR2 and/or FGFR3 gene alterations (NCT05242822).

    https://meetings.asco.org/abstracts-presentations/213092

Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.